Emergence of the silicon human and network targeting drugs-Reference-Cited by-同舟云学术

Emergence of the silicon human and network targeting drugs

Published:2012-07 Issue:4 Volume:46 Page:190-197
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Kolodkin Alexey,Boogerd Fred C.,Plant Nick,Bruggeman Frank J.,Goncharuk Valeri,Lunshof Jeantine,Moreno-Sanchez Rafael,Yilmaz Nilgun,Bakker Barbara M.,Snoep Jacky L.,Balling Rudi,Westerhoff Hans V.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference49 articles.

1. Evidence for importin alpha independent nuclear translocation of glucocorticoid receptors in Xenopus laevis oocytes;Albermann;Cell. Physiol. Biochem.,2004

2. Multitarget-directed drug design strategy: a novel molecule designed to block epidermal growth factor receptor (EGFR) and to exert proapoptotic effects;Antonello;J. Med. Chem.,2006

3. Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR;Aouabdi;Drug Metab. Dispos.,2006

4. Network-based selectivity of antiparasitic inhibitors;Bakker;Mol. Biol. Rep.,2002

5. Compartmentation protects trypanosomes from the dangerous design of glycolysis;Bakker;Proc. Natl. Acad. Sci. USA,2000

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Cancer Reversible? Rethinking Carcinogenesis Models—A New Epistemological Tool;Biomolecules;2023-04-24

2. Multiscale Process Modelling in Translational Systems Biology of Leishmania major: A Holistic view;Scientific Reports;2020-01-21

3. Revisiting the Concept of Human Disease;Approaching Complex Diseases;2020

4. In Vitro and In Vivo Pipeline for Validation of Disease-Modifying Effects of Systems Biology-Derived Network Treatments for Traumatic Brain Injury—Lessons Learned;International Journal of Molecular Sciences;2019-10-29

5. Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs;Expert Opinion on Drug Metabolism & Toxicology;2018-07-03